Prognostic impact of the expression of NCR1 and NCR3 NK cell receptors and PD-L1 on advanced non-small cell lung cancer
Laetitia Fend(Transgene (France)), Laurence Zitvogel(Institut Gustave Roussy), Isabelle Cremer(Délégation Paris 5), Sylvie Rusakiewicz(Inserm), Michaëla Semeraro(Délégation Paris 5), Christina Iribarren(Délégation Paris 5), Meriem Messaoudene(Centre Hospitalier de l’Université de Montréal), Aurélien Marabelle(Institut Gustave Roussy), Jean‐Marc Limacher(Transgene (France)), Guido Kroemer(Institut Universitaire de France), Anne Caignard(Inserm), Bérangère Bastien(Transgene (France)), Christophe Borg(Inserm), Alexander Eggermont(University Medical Center Utrecht), Luc Barraud(Transgene (France)), Julien Adam(Inserm)
Cited by 39
Related Papers
Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
|Science|2017|5.4k
Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009
|Cell Death and Differentiation|2008|3.3k
The molecular machinery of regulated cell death
|Cell Research|2019|2.5k
Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012
|Cell Death and Differentiation|2011|2.4k
Autophagy in major human diseases
|The EMBO Journal|2021|1.6k